ValiRx PLC - Result of GM, Issue of Equity

London, UK- ValiRx Plc, a life science company focusing on early-stage cancer therapeutics and women's health announces that at its General Meeting held earlier today, resolutions 1- 3 were duly passed and resolution 4 was withdrawn. The Company has therefore allotted a total of 12,145,454 new ordinary shares in connection with the Fundraising, raising £1.3...